Symtomax have submitted their application for licenses to cultivate, manufacture, distribute, import and export medical cannabis. Chairman of the Symtomax Group Paul Segal commented “this marks a very exciting time for Symtomax, having performed some very in depth feasibility studies; Portugal was the clear leader in our expansion plans. Not only does it offer an ideal climate for growing, it has a reputable agricultural and well developed transport infrastructure, together with a highly skilled workforce”